Resources & Updates.
Find the latest news, blogs, publications & grants.
Latest News & Articles
Browse updates, press, and explainers.
Dec 2, 2025
WittGen Makes US Debut at SABCS 2025 with Breakthrough Insights on T-DXd Resistance
WittGen debuts at San Antonio Breast Cancer Symposium, presenting research on pre-existing TOP2A-high cells driving resistance to Trastuzumab Deruxtecan in HER2+ breast cancer.
Read more
Oct 23, 2025
USPTO Approves AI-Powered Cancer Diagnostics Patent
U.S. Patent and Trademark Office issues Notice of Allowance for foundational patent in AI-driven single-cell tumor analysis.
Read more
Jul 4, 2025
Reflecting on WittGen's First Half of 2025
Key milestones including GenAI vision unveiling, service expansion from preclinical to clinical stages, and LEIBER-X platform debut at Bio USA.
Read more
Sep 20, 2024
Small Booth, Big Impact at BioTechX USA 2024
WittGen showcased its single-cell machine learning platform for clinical development, attracting interest from pharmaceutical and biotech companies.
Read more
Nov 7, 2023
WittGen Announces Prestigious Investors and Supporters
WittGen Biotechnologies announces backing from major investors including Primer, Hatcher+, and Plug and Play Tech Center.
Read more
Nov 1, 2023
New Office at CITRIS Foundry Hub, UC Berkeley
WittGen selected to the competitive CITRIS Foundry Fall 2023 program and opened a new office at Sutardja Dai Hall.
Read more